November 19, 12:00-1:00 p.m. ET This month's seminar will feature Charles Sawyers, MD, from Memorial Sloan Kettering. He'll be sharing his research from the Drug Resistance and Sensitivity Network (DRSN), which was implemented in response to the Blue Ribbon Panel Recommendation to develop ways to overcome cancer's resistance to therapy. |
No comments:
Post a Comment